cisapride is a substituted benzamide compound that stimulates motor activity in all segments of the gastrointestinal tract by enhancing the release of acetylcholine from the enteric nervous systemcisapride is administered orally in the treatment of gastrooesophageal reflux disease functional dyspepsia gastroparesis chronic intestinal pseudoobstruction syndromes and chronic constipationin gastrooesophageal reflux disease in both adults and children cisapride provides symptomatic improvement and mucosal healinglong term treatment with cisapride is effective in the prevention of relapse of oesophagitiscisapride improves gastric emptying rates and improves symptoms in patients with gastroparesis of various originsunlike domperidone and metoclopramide long term administration of cisapride seems to result in persistently enhanced gastric emptyingcisapride is also effective in improving symptoms in patients with functional dyspepsiain comparative studies in patients with functional dyspepsia cisapride was at least as effective as metoclopramide domperidone clebopride ranitidine and cimetidinecisapride increases stool frequency and reduces laxative consumption in patients with idiopathic constipationsevere cases of slow transit constipation seem refractory to cisaprideclinical studies also indicate that cisapride might be effective in the treatment of chronic intestinal pseudoobstruction postoperative ileus peptic ulcer and irritable bowel syndromefurther clinical studies are warranted to define the role of cisapride in these conditionsthe dosage of cisapride ranges from 5mg 3 times daily to 20mg twice dailycisapride is generally well tolerated both during short and long term treatmentin children cisapride is also well tolerated in doses of 02 to 03 mgkg 3 to 4 times dailyabstract truncated at 250 words